State of Maine v. Rochelle Gleason

2025 ME 52
Supreme Judicial Court of Maine·Decided June 17, 2025·No. Pen-24-248·Published

Opinion

MAINE SUPREME JUDICIAL COURT Reporter of Decisions Decision: 2025 ME 52 Docket: Pen-24-248 Argued: April 9, 2025 Decided: June 17, 2025

Panel: STANFILL, C.J., and MEAD, HORTON, CONNORS, LAWRENCE, DOUGLAS, and LIPEZ, JJ.

STATE OF MAINE

v.

ROCHELLE GLEASON

MEAD, J.

[¶1] Rochelle Gleason appeals from a judgment of conviction of aggravated trafficking of a scheduled drug that in fact caused the death of a person (Class A), 17-A M.R.S § 1105-A(1)(K) (2025), entered by the trial court (Penobscot County, Mallonee, J.) after a jury trial. On appeal, Gleason raises an issue concerning her Sixth Amendment right to confront the people who performed several toxicology tests that served as the basis for an expert toxicologist’s opinion testimony. The United States Supreme Court’s decision in Smith v. Arizona, 602 U.S. ---, 144 S. Ct. 1785 (2024), which was issued during the pendency of this appeal,1 did away with a line of reasoning that the trial

1 The appeal has been pending since May 16, 2024. The Supreme Court issued its decision in Smith v. Arizona, 602 U.S. ---, 144 S. Ct. 1785 (2024), on June 21, 2024. In Griffith v. Kentucky, the Supreme Court held that “a new rule for the conduct of criminal prosecutions is to be applied

court relied upon when it admitted the expert toxicologist’s testimony. We vacate the judgment and remand for a new trial.

I. BACKGROUND

A. Factual Background

[¶2] Viewing the evidence in the light most favorable to its verdict, the jury rationally could have found the following facts. See State v. Fay, 2015 ME 160, ¶ 2, 130 A.3d 364.

[¶3] In October 2021, Gleason and the decedent communicated regularly regarding the purchase of fentanyl and heroin, often using slang like “fingy,” “fetty,” “brown,” and “down.” On October 16, 2021, the decedent messaged Gleason asking to purchase more drugs. Gleason responded with a voice message for the decedent, stating that she had some “dark, dark shit that is expensive but worth it.” She continued that she had acquired some “fire, harsher shit” and added that she could get him $40 worth. The decedent agreed.

[¶4] Later that evening, the decedent drove with his twelve-year-old daughter to Third Street in Bangor. His daughter remained in the car while he

retroactively to all cases, state or federal, pending on direct review or not yet final.” 479 U.S. 314, 328 (1987); accord State v. Labbe, 2024 ME 15, ¶ 39, 314 A.3d 162. Because this case is on direct review, the rule announced in Smith applies retroactively in this case.

met with Gleason. His daughter observed the decedent exchange money for something. The decedent returned home and said goodnight to his daughter. He then consumed the fentanyl that he had purchased from Gleason, along with a nonscheduled but potentially lethal fentanyl metabolite called kratom or mytragynine. The decedent died of acute intoxication shortly after consuming the drugs.

[¶5] The Maine Office of the Chief Medical Examiner sent a sample of the decedent’s blood to the NMS Forensic Toxicology Laboratory in Pennsylvania. At the lab, several lab employees conducted a series of tests on the sample. The tests included two separate screening tests that screened for a wide variety of compounds and a confirmatory test to quantify any substance for which the screening produced positive results. The lab, at the request of the Chief Medical Examiner, also ran confirmatory tests specifically aimed at determining the presence and quantity of fentanyl and kratom in the decedent’s blood. Two different lab employees reviewed the results of the tests to determine whether the instruments were accurate, there were no anomalies, and appropriate protocols were being followed. After each test, a lab employee exported the data from the testing instruments to a computer. A forensic toxicologist who also works for NMS Laboratory, Chelsea Deisher, then conducted another

review of the data and the documentation. Deisher had a record of everyone who prepared the samples and conducted a review of the data, but she did not have a record of the employees who had operated the instruments during the tests or the employees who had exported the data from the instrument to the computer. Relying upon the results and data obtained by the other employees, Deisher then developed a toxicology report that revealed that the decedent’s blood contained 26 nanograms per milliliter of fentanyl, 1.8 nanograms per milliliter of norfentanyl (a breakdown product of fentanyl), and 22 nanograms per milliliter of kratom. B. Procedural History

[¶6] On September 28, 2022, the State charged Gleason by complaint with aggravated trafficking of a scheduled drug that in fact caused the death of a person (Class A), 17-A M.R.S. § 1105-A(1)(K). Gleason pleaded not guilty.

[¶7] The court held a five-day trial from April 29 to May 3, 2024. At trial, Deisher testified for the State about the results of several tests. Deisher explained that she had not actually conducted the tests but rather had reviewed the data and documentation and had analyzed the results. Gleason objected to this testimony and moved for a mistrial on the ground that the testimony violated her Sixth Amendment Confrontation Clause right because she did not

have an opportunity to cross-examine the actual testers to question whether the test sequences and procedures were properly followed. After hearing additional testimony outside of the presence of the jury, the court allowed Deisher to continue testifying.

[¶8] Later, a deputy chief medical examiner testified that the results that Deisher discussed during her testimony indicated that the decedent had a toxic level of fentanyl in the blood and died of acute intoxication due to the combined effects of fentanyl and kratom.

[¶9] The jury returned a verdict of guilty. On May 16, 2024, the court held a sentencing hearing at which it sentenced Gleason to eighteen years’ imprisonment, with all but eight years suspended, and four years of probation.

[¶10] Gleason timely appealed. See M.R. App. P. 2B(b)(1); 15 M.R.S.

§ 2115 (2025).

II. DISCUSSION

[¶11] The Confrontation Clause of the Sixth Amendment to the United States Constitution provides that “[i]n all criminal prosecutions, the accused shall enjoy the right . . . to be confronted with the witnesses against him.” U.S. Const. amend. VI. The federal Confrontation Clause applies to the states through the Fourteenth Amendment. Melendez-Diaz v. Massachusetts, 557 U.S.

305, 309 (2009); accord State v. Jones, 2018 ME 17, ¶ 8, 178 A.3d 481. “We review de novo the impact of the admission of testimony on the constitutional right to confront witnesses.” State v. Judkins, 2024 ME 45, ¶ 11, 319 A.3d 443 (quotation marks omitted).

[¶12] The Confrontation Clause operates by prohibiting the “admission of testimonial statements of a witness who did not appear at trial unless [that witness] was unavailable to testify, and the defendant had had a prior opportunity for cross-examination.” Crawford v. Washington, 541 U.S. 36, 53-54 (2004). The Confrontation Clause applies only to statements that are both (1) hearsay—meaning out-of-court statements offered “to prove the truth of the matter asserted,” id. at 59 n.9, 60; see M.R. Evid. 801(c), and (2) testimonial. See State v. Lovell, 2022 ME 49, ¶ 13, 281 A.3d 651. A. Hearsay

Free access — add to your briefcase to read the full text and ask questions with AI

State of Maine v. Rochelle Gleason, 2025 ME 52 (Me. 2025).

2025 ME 52 (State of Maine v. Rochelle Gleason) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

State of Maine v. Heather Marichal
Supreme Judicial Court of Maine, 2026
State of Maine v. Jayme Schnackenberg
Supreme Judicial Court of Maine, 2026
State of Maine v. Kenneth Rhoades
2026 ME 23 (Supreme Judicial Court of Maine, 2026)